Notably, FAM134B was found to be among a subset of genes that are upregulated in chronic myeloid leukemia (CML) cells and is correlated with pro-survival phenotypes and poor prognosis. The gene discussed is RETREG1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.